NRx Pharmaceuticals, Inc. today announced its financial results for the third quarter of 2022 and provided a business and clinical update.
Financial Results
Nov. 14, 2022
NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Aug. 15, 2022
NRx Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Results Focusing on Reactivation & Advancement of its Psychiatry Franchise
NRx Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2022 and provided a business and clinical update.
May. 16, 2022
NRx Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, NRx Pharmaceuticals), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter ended March 31, 2022 and provided a business and clinical update.
Mar. 31, 2022
NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Results
NRx Pharmaceuticals, Inc. today announced its financial results for the year ended December 31, 2021 and provided a business update.